FinTrust Capital Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-165
Closed -$8K 1306
2021
Q4
$8K Sell
165
-12
-7% -$582 ﹤0.01% 956
2021
Q3
$10K Hold
177
﹤0.01% 915
2021
Q2
$8K Hold
177
﹤0.01% 969
2021
Q1
$7K Hold
177
﹤0.01% 970
2020
Q4
$8K Hold
177
﹤0.01% 896
2020
Q3
$8 Buy
177
+140
+378% +$6 ﹤0.01% 865
2020
Q2
$2K Sell
37
-52
-58% -$2.81K ﹤0.01% 966
2020
Q1
$4K Hold
89
﹤0.01% 925
2019
Q4
$5K Hold
89
﹤0.01% 873
2019
Q3
$5K Buy
89
+7
+9% +$393 ﹤0.01% 872
2019
Q2
$5K Hold
82
﹤0.01% 849
2019
Q1
$4K Sell
82
-369
-82% -$18K ﹤0.01% 997
2018
Q4
$18K Buy
+451
New +$18K 0.01% 621